[Progress of study on suppressor of cytokine signaling-1 - review]

Hai-Ping Yang1, Min Dai, Dong-Hua Zhang

  • 1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

Insights

Suppressor of cytokine signaling-1 (SOCS-1) protein regulates immune responses by inhibiting cytokine signaling. Its abnormal expression is linked to diseases like leukemia and liver cancer.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Cytokines are crucial signaling molecules in immunity and cell regulation.
  • The Suppressor of Cytokine Signaling (SOCS) family, particularly SOCS-1, acts as a negative feedback regulator.
  • SOCS-1 is a key inhibitor of various cytokine signaling pathways.

Purpose of the Study:

  • To review the advances in research on SOCS-1.
  • To summarize the relationship between SOCS-1 and cytokine signaling.
  • To explore the correlation between SOCS-1 and human diseases.

Main Methods:

  • Literature review of studies on SOCS-1.
  • Analysis of SOCS-1's role in cytokine signal transduction.
  • Examination of SOCS-1's involvement in disease pathogenesis.

Main Results:

  • SOCS-1 inhibits signaling pathways of cytokines like IL-6, LIF, OSM, INF-gamma, and GH.
  • These cytokines regulate critical in vivo immune responses.
  • Abnormal SOCS-1 expression is associated with leukemia, rheumatoid arthritis, liver cirrhosis, and liver cancer.

Conclusions:

  • SOCS-1 is a vital regulator of cytokine signaling.
  • Dysregulation of SOCS-1 is implicated in the development of significant human diseases.
  • Further research into SOCS-1 holds potential for understanding and treating these conditions.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...